nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.234	1	CpDpCtD
Dexamethasone—CYP11A1—uterine cancer	0.0914	0.44	CbGaD
Dexamethasone—PGR—uterine cancer	0.0689	0.332	CbGaD
Dexamethasone—CYP19A1—uterine cancer	0.0473	0.228	CbGaD
Dexamethasone—NR3C2—Progesterone—uterine cancer	0.0278	0.11	CbGbCtD
Dexamethasone—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0271	0.107	CbGbCtD
Dexamethasone—CYP17A1—Progesterone—uterine cancer	0.026	0.103	CbGbCtD
Dexamethasone—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.0223	0.113	CrCrCtD
Dexamethasone—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0197	0.0996	CrCrCtD
Dexamethasone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0181	0.0915	CrCrCtD
Dexamethasone—PGR—Progesterone—uterine cancer	0.018	0.0712	CbGbCtD
Dexamethasone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0176	0.0891	CrCrCtD
Dexamethasone—Testolactone—Progesterone—uterine cancer	0.0171	0.0868	CrCrCtD
Dexamethasone—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0163	0.0828	CrCrCtD
Dexamethasone—NOS2—Doxorubicin—uterine cancer	0.016	0.0632	CbGbCtD
Dexamethasone—Fluoxymesterone—Progesterone—uterine cancer	0.0157	0.0798	CrCrCtD
Dexamethasone—Fludrocortisone—Progesterone—uterine cancer	0.0153	0.0777	CrCrCtD
Dexamethasone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0153	0.0774	CrCrCtD
Dexamethasone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.0144	0.0727	CrCrCtD
Dexamethasone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0139	0.0549	CbGbCtD
Dexamethasone—Prednisolone—Progesterone—uterine cancer	0.013	0.066	CrCrCtD
Dexamethasone—Hydrocortisone—Progesterone—uterine cancer	0.0125	0.0634	CrCrCtD
Dexamethasone—CYP1B1—Progesterone—uterine cancer	0.0125	0.0494	CbGbCtD
Dexamethasone—ABCB11—Progesterone—uterine cancer	0.0125	0.0494	CbGbCtD
Dexamethasone—NR3C1—Progesterone—uterine cancer	0.00918	0.0364	CbGbCtD
Dexamethasone—CYP2A6—Progesterone—uterine cancer	0.00641	0.0254	CbGbCtD
Dexamethasone—CYP1A1—Progesterone—uterine cancer	0.00548	0.0217	CbGbCtD
Dexamethasone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.00477	0.0189	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—uterine cancer	0.0047	0.0186	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.00438	0.0173	CbGbCtD
Dexamethasone—CYP3A7—Progesterone—uterine cancer	0.00438	0.0173	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—uterine cancer	0.00381	0.0151	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—uterine cancer	0.00381	0.0151	CbGbCtD
Dexamethasone—ABCC2—Carboplatin—uterine cancer	0.0035	0.0138	CbGbCtD
Dexamethasone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00333	0.0132	CbGbCtD
Dexamethasone—CYP3A5—Progesterone—uterine cancer	0.00329	0.013	CbGbCtD
Dexamethasone—ABCG2—Carboplatin—uterine cancer	0.00316	0.0125	CbGbCtD
Dexamethasone—CYP2C8—Progesterone—uterine cancer	0.00316	0.0125	CbGbCtD
Dexamethasone—ABCC2—Etoposide—uterine cancer	0.00294	0.0116	CbGbCtD
Dexamethasone—PTGS2—Etoposide—uterine cancer	0.0029	0.0115	CbGbCtD
Dexamethasone—ABCG2—Etoposide—uterine cancer	0.00265	0.0105	CbGbCtD
Dexamethasone—CYP2C19—Progesterone—uterine cancer	0.00265	0.0105	CbGbCtD
Dexamethasone—CYP11A1—corpus luteum—uterine cancer	0.00262	0.0935	CbGeAlD
Dexamethasone—CYP2C9—Progesterone—uterine cancer	0.0022	0.00873	CbGbCtD
Dexamethasone—ABCB1—Progesterone—uterine cancer	0.00214	0.00847	CbGbCtD
Dexamethasone—CYP2D6—Progesterone—uterine cancer	0.00202	0.00798	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—uterine cancer	0.002	0.00793	CbGbCtD
Dexamethasone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00766	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—uterine cancer	0.00189	0.00749	CbGbCtD
Dexamethasone—PGR—corpus luteum—uterine cancer	0.00189	0.0675	CbGeAlD
Dexamethasone—ABCG2—Doxorubicin—uterine cancer	0.00181	0.00717	CbGbCtD
Dexamethasone—CYP19A1—corpus luteum—uterine cancer	0.0017	0.0607	CbGeAlD
Dexamethasone—ABCB1—Dactinomycin—uterine cancer	0.0017	0.00672	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—uterine cancer	0.00147	0.00582	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—uterine cancer	0.00141	0.0056	CbGbCtD
Dexamethasone—CYP3A4—Progesterone—uterine cancer	0.00128	0.00507	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—uterine cancer	0.00127	0.00504	CbGbCtD
Dexamethasone—ANXA1—oviduct—uterine cancer	0.00108	0.0385	CbGeAlD
Dexamethasone—ABCB1—Etoposide—uterine cancer	0.000957	0.00379	CbGbCtD
Dexamethasone—PLA2G1B—exocrine gland—uterine cancer	0.000815	0.0291	CbGeAlD
Dexamethasone—CYP19A1—semen—uterine cancer	0.000797	0.0284	CbGeAlD
Dexamethasone—ABCB1—Doxorubicin—uterine cancer	0.000653	0.00258	CbGbCtD
Dexamethasone—PGR—oviduct—uterine cancer	0.00065	0.0232	CbGeAlD
Dexamethasone—ANXA1—exocrine gland—uterine cancer	0.000623	0.0222	CbGeAlD
Dexamethasone—CYP2D6—Doxorubicin—uterine cancer	0.000615	0.00244	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—uterine cancer	0.000573	0.00227	CbGbCtD
Dexamethasone—PGR—artery—uterine cancer	0.00043	0.0154	CbGeAlD
Dexamethasone—CYP4A11—renal system—uterine cancer	0.000397	0.0142	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—uterine cancer	0.000391	0.00155	CbGbCtD
Dexamethasone—NR0B1—female reproductive system—uterine cancer	0.000369	0.0132	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—uterine cancer	0.000354	0.0126	CbGeAlD
Dexamethasone—ANXA1—myometrium—uterine cancer	0.000345	0.0123	CbGeAlD
Dexamethasone—NR0B1—female gonad—uterine cancer	0.000336	0.012	CbGeAlD
Dexamethasone—PLA2G1B—renal system—uterine cancer	0.000329	0.0117	CbGeAlD
Dexamethasone—CYP4A11—vagina—uterine cancer	0.000287	0.0103	CbGeAlD
Dexamethasone—ANXA1—epithelium—uterine cancer	0.000271	0.00967	CbGeAlD
Dexamethasone—ANXA1—uterine cervix—uterine cancer	0.000269	0.00959	CbGeAlD
Dexamethasone—PLA2G1B—female reproductive system—uterine cancer	0.000263	0.0094	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—uterine cancer	0.000261	0.00932	CbGeAlD
Dexamethasone—ANXA1—decidua—uterine cancer	0.000256	0.00914	CbGeAlD
Dexamethasone—ANXA1—renal system—uterine cancer	0.000251	0.00897	CbGeAlD
Dexamethasone—ANXA1—endometrium—uterine cancer	0.000243	0.00867	CbGeAlD
Dexamethasone—PLA2G1B—female gonad—uterine cancer	0.00024	0.00855	CbGeAlD
Dexamethasone—ANXA1—mammalian vulva—uterine cancer	0.000235	0.00839	CbGeAlD
Dexamethasone—CYP17A1—renal system—uterine cancer	0.000225	0.00804	CbGeAlD
Dexamethasone—ANXA1—uterus—uterine cancer	0.000224	0.00799	CbGeAlD
Dexamethasone—NR3C2—myometrium—uterine cancer	0.000224	0.00798	CbGeAlD
Dexamethasone—PTGS2—artery—uterine cancer	0.000215	0.00767	CbGeAlD
Dexamethasone—Testolactone—CYP19A1—uterine cancer	0.000215	0.328	CrCbGaD
Dexamethasone—CYP11A1—decidua—uterine cancer	0.000213	0.00762	CbGeAlD
Dexamethasone—PGR—myometrium—uterine cancer	0.000208	0.00742	CbGeAlD
Dexamethasone—ANXA1—female reproductive system—uterine cancer	0.000201	0.00719	CbGeAlD
Dexamethasone—ANXA1—female gonad—uterine cancer	0.000183	0.00654	CbGeAlD
Dexamethasone—ANXA1—vagina—uterine cancer	0.000182	0.0065	CbGeAlD
Dexamethasone—CYP17A1—female reproductive system—uterine cancer	0.00018	0.00644	CbGeAlD
Dexamethasone—NR3C2—uterine cervix—uterine cancer	0.000174	0.00621	CbGeAlD
Dexamethasone—NR3C2—smooth muscle tissue—uterine cancer	0.000169	0.00604	CbGeAlD
Dexamethasone—CYP11A1—female reproductive system—uterine cancer	0.000168	0.00599	CbGeAlD
Dexamethasone—CYP17A1—female gonad—uterine cancer	0.000164	0.00586	CbGeAlD
Dexamethasone—PGR—epithelium—uterine cancer	0.000163	0.00582	CbGeAlD
Dexamethasone—NR3C2—renal system—uterine cancer	0.000163	0.00581	CbGeAlD
Dexamethasone—PGR—uterine cervix—uterine cancer	0.000162	0.00577	CbGeAlD
Dexamethasone—NR3C2—endometrium—uterine cancer	0.000157	0.00562	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—uterine cancer	0.000157	0.00561	CbGeAlD
Dexamethasone—PGR—decidua—uterine cancer	0.000154	0.0055	CbGeAlD
Dexamethasone—CYP11A1—female gonad—uterine cancer	0.000153	0.00545	CbGeAlD
Dexamethasone—NR3C2—mammalian vulva—uterine cancer	0.000152	0.00543	CbGeAlD
Dexamethasone—PGR—endometrium—uterine cancer	0.000146	0.00522	CbGeAlD
Dexamethasone—NR3C2—uterus—uterine cancer	0.000145	0.00518	CbGeAlD
Dexamethasone—SLCO1A2—renal system—uterine cancer	0.00014	0.00498	CbGeAlD
Dexamethasone—PGR—uterus—uterine cancer	0.000135	0.00481	CbGeAlD
Dexamethasone—Fluticasone Propionate—PGR—uterine cancer	0.000134	0.205	CrCbGaD
Dexamethasone—CYP1B1—smooth muscle tissue—uterine cancer	0.000132	0.00472	CbGeAlD
Dexamethasone—CYP19A1—endometrium—uterine cancer	0.000132	0.0047	CbGeAlD
Dexamethasone—NR3C2—female reproductive system—uterine cancer	0.00013	0.00465	CbGeAlD
Dexamethasone—ABCG2—myometrium—uterine cancer	0.00013	0.00465	CbGeAlD
Dexamethasone—ABCC2—renal system—uterine cancer	0.00013	0.00464	CbGeAlD
Dexamethasone—CYP1B1—decidua—uterine cancer	0.00013	0.00463	CbGeAlD
Dexamethasone—CYP1B1—renal system—uterine cancer	0.000127	0.00454	CbGeAlD
Dexamethasone—CYP2A6—vagina—uterine cancer	0.000126	0.00449	CbGeAlD
Dexamethasone—Betamethasone—PGR—uterine cancer	0.000123	0.187	CrCbGaD
Dexamethasone—CYP19A1—uterus—uterine cancer	0.000121	0.00433	CbGeAlD
Dexamethasone—PGR—female reproductive system—uterine cancer	0.000121	0.00433	CbGeAlD
Dexamethasone—NR3C1—myometrium—uterine cancer	0.00012	0.00428	CbGeAlD
Dexamethasone—NR3C2—female gonad—uterine cancer	0.000119	0.00423	CbGeAlD
Dexamethasone—NR3C2—vagina—uterine cancer	0.000118	0.00421	CbGeAlD
Dexamethasone—ANXA1—lymph node—uterine cancer	0.000118	0.0042	CbGeAlD
Dexamethasone—CYP1B1—uterus—uterine cancer	0.000113	0.00405	CbGeAlD
Dexamethasone—PGR—female gonad—uterine cancer	0.00011	0.00394	CbGeAlD
Dexamethasone—PGR—vagina—uterine cancer	0.00011	0.00391	CbGeAlD
Dexamethasone—CYP19A1—female reproductive system—uterine cancer	0.000109	0.00389	CbGeAlD
Dexamethasone—CYP17A1—lymph node—uterine cancer	0.000106	0.00377	CbGeAlD
Dexamethasone—ABCC2—female reproductive system—uterine cancer	0.000104	0.00372	CbGeAlD
Dexamethasone—PTGS2—myometrium—uterine cancer	0.000104	0.0037	CbGeAlD
Dexamethasone—CYP1B1—female reproductive system—uterine cancer	0.000102	0.00364	CbGeAlD
Dexamethasone—ABCG2—uterine cervix—uterine cancer	0.000101	0.00362	CbGeAlD
Dexamethasone—Fluoxymesterone—ESR1—uterine cancer	9.95e-05	0.152	CrCbGaD
Dexamethasone—CYP19A1—female gonad—uterine cancer	9.92e-05	0.00354	CbGeAlD
Dexamethasone—CYP11A1—lymph node—uterine cancer	9.82e-05	0.0035	CbGeAlD
Dexamethasone—CYP2C8—renal system—uterine cancer	9.75e-05	0.00348	CbGeAlD
Dexamethasone—CYP1A1—epithelium—uterine cancer	9.7e-05	0.00346	CbGeAlD
Dexamethasone—ABCG2—decidua—uterine cancer	9.65e-05	0.00345	CbGeAlD
Dexamethasone—CYP1A1—uterine cervix—uterine cancer	9.62e-05	0.00343	CbGeAlD
Dexamethasone—CYP2C8—endometrium—uterine cancer	9.42e-05	0.00336	CbGeAlD
Dexamethasone—NR3C1—epithelium—uterine cancer	9.41e-05	0.00336	CbGeAlD
Dexamethasone—CYP3A5—uterine cervix—uterine cancer	9.4e-05	0.00336	CbGeAlD
Dexamethasone—NR3C1—uterine cervix—uterine cancer	9.33e-05	0.00333	CbGeAlD
Dexamethasone—CYP1B1—female gonad—uterine cancer	9.28e-05	0.00331	CbGeAlD
Dexamethasone—ABCG2—endometrium—uterine cancer	9.16e-05	0.00327	CbGeAlD
Dexamethasone—NR3C1—smooth muscle tissue—uterine cancer	9.07e-05	0.00324	CbGeAlD
Dexamethasone—CYP1A1—renal system—uterine cancer	9e-05	0.00321	CbGeAlD
Dexamethasone—NR3C1—decidua—uterine cancer	8.89e-05	0.00317	CbGeAlD
Dexamethasone—ABCG2—mammalian vulva—uterine cancer	8.86e-05	0.00316	CbGeAlD
Dexamethasone—CYP3A5—renal system—uterine cancer	8.8e-05	0.00314	CbGeAlD
Dexamethasone—CYP2B6—renal system—uterine cancer	8.74e-05	0.00312	CbGeAlD
Dexamethasone—NR3C1—renal system—uterine cancer	8.73e-05	0.00312	CbGeAlD
Dexamethasone—ABCG2—uterus—uterine cancer	8.44e-05	0.00301	CbGeAlD
Dexamethasone—NR3C1—endometrium—uterine cancer	8.44e-05	0.00301	CbGeAlD
Dexamethasone—Betamethasone—CYP19A1—uterine cancer	8.42e-05	0.129	CrCbGaD
Dexamethasone—CYP1A1—mammalian vulva—uterine cancer	8.42e-05	0.003	CbGeAlD
Dexamethasone—CYP2E1—renal system—uterine cancer	8.21e-05	0.00293	CbGeAlD
Dexamethasone—NR3C1—mammalian vulva—uterine cancer	8.16e-05	0.00291	CbGeAlD
Dexamethasone—PTGS2—epithelium—uterine cancer	8.15e-05	0.00291	CbGeAlD
Dexamethasone—CYP2C19—vagina—uterine cancer	8.09e-05	0.00289	CbGeAlD
Dexamethasone—PTGS2—uterine cervix—uterine cancer	8.08e-05	0.00288	CbGeAlD
Dexamethasone—CYP1A1—uterus—uterine cancer	8.02e-05	0.00286	CbGeAlD
Dexamethasone—PTGS2—smooth muscle tissue—uterine cancer	7.85e-05	0.0028	CbGeAlD
Dexamethasone—CYP2C8—female reproductive system—uterine cancer	7.81e-05	0.00279	CbGeAlD
Dexamethasone—NR3C1—uterus—uterine cancer	7.78e-05	0.00278	CbGeAlD
Dexamethasone—NR3C2—lymph node—uterine cancer	7.63e-05	0.00272	CbGeAlD
Dexamethasone—PTGS2—renal system—uterine cancer	7.56e-05	0.0027	CbGeAlD
Dexamethasone—PTGS2—endometrium—uterine cancer	7.31e-05	0.00261	CbGeAlD
Dexamethasone—CYP1A1—female reproductive system—uterine cancer	7.21e-05	0.00257	CbGeAlD
Dexamethasone—PGR—lymph node—uterine cancer	7.09e-05	0.00253	CbGeAlD
Dexamethasone—CYP2C8—vagina—uterine cancer	7.06e-05	0.00252	CbGeAlD
Dexamethasone—CYP2B6—female reproductive system—uterine cancer	7e-05	0.0025	CbGeAlD
Dexamethasone—NR3C1—female reproductive system—uterine cancer	6.99e-05	0.0025	CbGeAlD
Dexamethasone—CYP2C9—female reproductive system—uterine cancer	6.93e-05	0.00248	CbGeAlD
Dexamethasone—ABCG2—female gonad—uterine cancer	6.91e-05	0.00247	CbGeAlD
Dexamethasone—ABCG2—vagina—uterine cancer	6.87e-05	0.00245	CbGeAlD
Dexamethasone—PTGS2—uterus—uterine cancer	6.73e-05	0.0024	CbGeAlD
Dexamethasone—CYP3A4—renal system—uterine cancer	6.6e-05	0.00236	CbGeAlD
Dexamethasone—CYP2E1—female reproductive system—uterine cancer	6.57e-05	0.00235	CbGeAlD
Dexamethasone—CYP1A1—female gonad—uterine cancer	6.56e-05	0.00234	CbGeAlD
Dexamethasone—CYP1A1—vagina—uterine cancer	6.52e-05	0.00233	CbGeAlD
Dexamethasone—CYP2D6—renal system—uterine cancer	6.5e-05	0.00232	CbGeAlD
Dexamethasone—ABCB1—myometrium—uterine cancer	6.42e-05	0.00229	CbGeAlD
Dexamethasone—CYP3A5—female gonad—uterine cancer	6.41e-05	0.00229	CbGeAlD
Dexamethasone—CYP19A1—lymph node—uterine cancer	6.38e-05	0.00228	CbGeAlD
Dexamethasone—CYP3A5—vagina—uterine cancer	6.37e-05	0.00227	CbGeAlD
Dexamethasone—NR3C1—female gonad—uterine cancer	6.36e-05	0.00227	CbGeAlD
Dexamethasone—CYP2B6—vagina—uterine cancer	6.33e-05	0.00226	CbGeAlD
Dexamethasone—NR3C1—vagina—uterine cancer	6.32e-05	0.00226	CbGeAlD
Dexamethasone—ABCC2—lymph node—uterine cancer	6.09e-05	0.00217	CbGeAlD
Dexamethasone—PTGS2—female reproductive system—uterine cancer	6.05e-05	0.00216	CbGeAlD
Dexamethasone—CYP1B1—lymph node—uterine cancer	5.96e-05	0.00213	CbGeAlD
Dexamethasone—Acute coronary syndrome—Etoposide—uterine cancer	5.71e-05	0.00129	CcSEcCtD
Dexamethasone—Body temperature increased—Progesterone—uterine cancer	5.71e-05	0.00129	CcSEcCtD
Dexamethasone—Abdominal pain—Progesterone—uterine cancer	5.71e-05	0.00129	CcSEcCtD
Dexamethasone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	5.69e-05	0.00129	CcSEcCtD
Dexamethasone—Ulcer—Doxorubicin—uterine cancer	5.68e-05	0.00129	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Etoposide—uterine cancer	5.68e-05	0.00129	CcSEcCtD
Dexamethasone—Myocardial infarction—Etoposide—uterine cancer	5.68e-05	0.00129	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	5.65e-05	0.00128	CcSEcCtD
Dexamethasone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	5.65e-05	0.00128	CcSEcCtD
Dexamethasone—Malaise—Dactinomycin—uterine cancer	5.64e-05	0.00128	CcSEcCtD
Dexamethasone—Skin exfoliation—Epirubicin—uterine cancer	5.54e-05	0.00125	CcSEcCtD
Dexamethasone—Fluid retention—Epirubicin—uterine cancer	5.51e-05	0.00125	CcSEcCtD
Dexamethasone—PTGS2—female gonad—uterine cancer	5.51e-05	0.00197	CbGeAlD
Dexamethasone—PTGS2—vagina—uterine cancer	5.47e-05	0.00195	CbGeAlD
Dexamethasone—Neuropathy—Epirubicin—uterine cancer	5.45e-05	0.00123	CcSEcCtD
Dexamethasone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	5.4e-05	0.00122	CcSEcCtD
Dexamethasone—Hiccups—Doxorubicin—uterine cancer	5.37e-05	0.00122	CcSEcCtD
Dexamethasone—Dry eye—Epirubicin—uterine cancer	5.36e-05	0.00121	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	5.35e-05	0.00121	CcSEcCtD
Dexamethasone—Myalgia—Dactinomycin—uterine cancer	5.33e-05	0.00121	CcSEcCtD
Dexamethasone—Dermatitis contact—Doxorubicin—uterine cancer	5.31e-05	0.0012	CcSEcCtD
Dexamethasone—Oesophagitis—Epirubicin—uterine cancer	5.31e-05	0.0012	CcSEcCtD
Dexamethasone—CYP3A4—female reproductive system—uterine cancer	5.29e-05	0.00189	CbGeAlD
Dexamethasone—Discomfort—Dactinomycin—uterine cancer	5.26e-05	0.00119	CcSEcCtD
Dexamethasone—Ecchymosis—Epirubicin—uterine cancer	5.25e-05	0.00119	CcSEcCtD
Dexamethasone—CYP2D6—female reproductive system—uterine cancer	5.2e-05	0.00186	CbGeAlD
Dexamethasone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	5.2e-05	0.00118	CcSEcCtD
Dexamethasone—Asthenia—Progesterone—uterine cancer	5.18e-05	0.00117	CcSEcCtD
Dexamethasone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	5.18e-05	0.00117	CcSEcCtD
Dexamethasone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	5.18e-05	0.00117	CcSEcCtD
Dexamethasone—Pulmonary oedema—Epirubicin—uterine cancer	5.17e-05	0.00117	CcSEcCtD
Dexamethasone—Skin exfoliation—Doxorubicin—uterine cancer	5.13e-05	0.00116	CcSEcCtD
Dexamethasone—Pruritus—Progesterone—uterine cancer	5.11e-05	0.00116	CcSEcCtD
Dexamethasone—Oedema—Dactinomycin—uterine cancer	5.11e-05	0.00116	CcSEcCtD
Dexamethasone—Fluid retention—Doxorubicin—uterine cancer	5.1e-05	0.00115	CcSEcCtD
Dexamethasone—Infection—Dactinomycin—uterine cancer	5.07e-05	0.00115	CcSEcCtD
Dexamethasone—Neuropathy—Doxorubicin—uterine cancer	5.05e-05	0.00114	CcSEcCtD
Dexamethasone—ABCB1—epithelium—uterine cancer	5.04e-05	0.0018	CbGeAlD
Dexamethasone—Thrombocytopenia—Dactinomycin—uterine cancer	5e-05	0.00113	CcSEcCtD
Dexamethasone—ABCB1—uterine cervix—uterine cancer	5e-05	0.00178	CbGeAlD
Dexamethasone—Dry eye—Doxorubicin—uterine cancer	4.96e-05	0.00112	CcSEcCtD
Dexamethasone—Diarrhoea—Progesterone—uterine cancer	4.94e-05	0.00112	CcSEcCtD
Dexamethasone—Oesophagitis—Doxorubicin—uterine cancer	4.91e-05	0.00111	CcSEcCtD
Dexamethasone—Thrombophlebitis—Epirubicin—uterine cancer	4.87e-05	0.0011	CcSEcCtD
Dexamethasone—Anorexia—Dactinomycin—uterine cancer	4.87e-05	0.0011	CcSEcCtD
Dexamethasone—Eye disorder—Etoposide—uterine cancer	4.86e-05	0.0011	CcSEcCtD
Dexamethasone—Ecchymosis—Doxorubicin—uterine cancer	4.86e-05	0.0011	CcSEcCtD
Dexamethasone—Diabetes mellitus—Epirubicin—uterine cancer	4.85e-05	0.0011	CcSEcCtD
Dexamethasone—Pulmonary oedema—Doxorubicin—uterine cancer	4.78e-05	0.00108	CcSEcCtD
Dexamethasone—Dizziness—Progesterone—uterine cancer	4.78e-05	0.00108	CcSEcCtD
Dexamethasone—ABCB1—decidua—uterine cancer	4.76e-05	0.0017	CbGeAlD
Dexamethasone—CYP2D6—female gonad—uterine cancer	4.73e-05	0.00169	CbGeAlD
Dexamethasone—Angiopathy—Etoposide—uterine cancer	4.72e-05	0.00107	CcSEcCtD
Dexamethasone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	4.7e-05	0.00106	CcSEcCtD
Dexamethasone—ABCB1—renal system—uterine cancer	4.67e-05	0.00167	CbGeAlD
Dexamethasone—Eye pain—Epirubicin—uterine cancer	4.67e-05	0.00106	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	4.65e-05	0.00105	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Epirubicin—uterine cancer	4.65e-05	0.00105	CcSEcCtD
Dexamethasone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	4.63e-05	0.00105	CcSEcCtD
Dexamethasone—Alopecia—Etoposide—uterine cancer	4.6e-05	0.00104	CcSEcCtD
Dexamethasone—Vomiting—Progesterone—uterine cancer	4.59e-05	0.00104	CcSEcCtD
Dexamethasone—Rash—Progesterone—uterine cancer	4.56e-05	0.00103	CcSEcCtD
Dexamethasone—Dermatitis—Progesterone—uterine cancer	4.55e-05	0.00103	CcSEcCtD
Dexamethasone—Headache—Progesterone—uterine cancer	4.53e-05	0.00102	CcSEcCtD
Dexamethasone—ABCB1—endometrium—uterine cancer	4.52e-05	0.00161	CbGeAlD
Dexamethasone—Thrombophlebitis—Doxorubicin—uterine cancer	4.51e-05	0.00102	CcSEcCtD
Dexamethasone—Increased appetite—Epirubicin—uterine cancer	4.49e-05	0.00102	CcSEcCtD
Dexamethasone—Diabetes mellitus—Doxorubicin—uterine cancer	4.48e-05	0.00101	CcSEcCtD
Dexamethasone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	4.48e-05	0.00101	CcSEcCtD
Dexamethasone—ABCG2—lymph node—uterine cancer	4.44e-05	0.00159	CbGeAlD
Dexamethasone—Decreased appetite—Dactinomycin—uterine cancer	4.44e-05	0.001	CcSEcCtD
Dexamethasone—Dermatitis bullous—Epirubicin—uterine cancer	4.41e-05	0.000998	CcSEcCtD
Dexamethasone—Fatigue—Dactinomycin—uterine cancer	4.4e-05	0.000997	CcSEcCtD
Dexamethasone—ABCB1—mammalian vulva—uterine cancer	4.37e-05	0.00156	CbGeAlD
Dexamethasone—Pain—Dactinomycin—uterine cancer	4.37e-05	0.000988	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Epirubicin—uterine cancer	4.36e-05	0.000986	CcSEcCtD
Dexamethasone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	4.33e-05	0.00098	CcSEcCtD
Dexamethasone—Eye pain—Doxorubicin—uterine cancer	4.32e-05	0.000978	CcSEcCtD
Dexamethasone—Cardiac failure—Epirubicin—uterine cancer	4.32e-05	0.000978	CcSEcCtD
Dexamethasone—Lethargy—Epirubicin—uterine cancer	4.3e-05	0.000974	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Doxorubicin—uterine cancer	4.3e-05	0.000973	CcSEcCtD
Dexamethasone—Nausea—Progesterone—uterine cancer	4.29e-05	0.000971	CcSEcCtD
Dexamethasone—Osteoarthritis—Epirubicin—uterine cancer	4.22e-05	0.000954	CcSEcCtD
Dexamethasone—CYP1A1—lymph node—uterine cancer	4.22e-05	0.0015	CbGeAlD
Dexamethasone—Feeling abnormal—Dactinomycin—uterine cancer	4.21e-05	0.000953	CcSEcCtD
Dexamethasone—Ill-defined disorder—Etoposide—uterine cancer	4.2e-05	0.000951	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Dactinomycin—uterine cancer	4.18e-05	0.000945	CcSEcCtD
Dexamethasone—ABCB1—uterus—uterine cancer	4.16e-05	0.00149	CbGeAlD
Dexamethasone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.16e-05	0.000942	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—uterine cancer	4.15e-05	0.00094	CcSEcCtD
Dexamethasone—Affect lability—Epirubicin—uterine cancer	4.15e-05	0.000939	CcSEcCtD
Dexamethasone—Migraine—Epirubicin—uterine cancer	4.15e-05	0.000939	CcSEcCtD
Dexamethasone—Rash—Medroxyprogesterone Acetate—uterine cancer	4.13e-05	0.000934	CcSEcCtD
Dexamethasone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.12e-05	0.000933	CcSEcCtD
Dexamethasone—Headache—Medroxyprogesterone Acetate—uterine cancer	4.1e-05	0.000928	CcSEcCtD
Dexamethasone—NR3C1—lymph node—uterine cancer	4.09e-05	0.00146	CbGeAlD
Dexamethasone—Malaise—Etoposide—uterine cancer	4.08e-05	0.000924	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—uterine cancer	4.08e-05	0.000924	CcSEcCtD
Dexamethasone—Vertigo—Etoposide—uterine cancer	4.07e-05	0.000921	CcSEcCtD
Dexamethasone—Body temperature increased—Dactinomycin—uterine cancer	4.04e-05	0.000914	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—uterine cancer	4.04e-05	0.000914	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.03e-05	0.000912	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—uterine cancer	4.01e-05	0.000907	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—uterine cancer	4e-05	0.000905	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—uterine cancer	3.99e-05	0.000904	CcSEcCtD
Dexamethasone—Loss of consciousness—Etoposide—uterine cancer	3.98e-05	0.000901	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—uterine cancer	3.98e-05	0.000901	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—uterine cancer	3.92e-05	0.000888	CcSEcCtD
Dexamethasone—Hypertension—Etoposide—uterine cancer	3.91e-05	0.000885	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—uterine cancer	3.9e-05	0.000883	CcSEcCtD
Dexamethasone—Nausea—Medroxyprogesterone Acetate—uterine cancer	3.89e-05	0.00088	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—uterine cancer	3.86e-05	0.000875	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—uterine cancer	3.84e-05	0.000869	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—uterine cancer	3.84e-05	0.000869	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—uterine cancer	3.84e-05	0.000868	CcSEcCtD
Dexamethasone—Discomfort—Etoposide—uterine cancer	3.81e-05	0.000862	CcSEcCtD
Dexamethasone—ABCB1—female reproductive system—uterine cancer	3.74e-05	0.00134	CbGeAlD
Dexamethasone—Muscular weakness—Epirubicin—uterine cancer	3.72e-05	0.000841	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—uterine cancer	3.71e-05	0.000839	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—uterine cancer	3.7e-05	0.000837	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—uterine cancer	3.7e-05	0.000836	CcSEcCtD
Dexamethasone—Infection—Etoposide—uterine cancer	3.67e-05	0.000831	CcSEcCtD
Dexamethasone—Asthenia—Dactinomycin—uterine cancer	3.66e-05	0.000829	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—uterine cancer	3.62e-05	0.000819	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—uterine cancer	3.61e-05	0.000816	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—uterine cancer	3.58e-05	0.000809	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—uterine cancer	3.57e-05	0.000809	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—uterine cancer	3.55e-05	0.000803	CcSEcCtD
Dexamethasone—PTGS2—lymph node—uterine cancer	3.54e-05	0.00126	CbGeAlD
Dexamethasone—Anorexia—Etoposide—uterine cancer	3.52e-05	0.000797	CcSEcCtD
Dexamethasone—Diarrhoea—Dactinomycin—uterine cancer	3.49e-05	0.000791	CcSEcCtD
Dexamethasone—Hypotension—Etoposide—uterine cancer	3.45e-05	0.000782	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—uterine cancer	3.44e-05	0.000779	CcSEcCtD
Dexamethasone—ABCB1—female gonad—uterine cancer	3.41e-05	0.00122	CbGeAlD
Dexamethasone—ABCB1—vagina—uterine cancer	3.39e-05	0.00121	CbGeAlD
Dexamethasone—Paraesthesia—Etoposide—uterine cancer	3.32e-05	0.000751	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—uterine cancer	3.32e-05	0.00075	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—uterine cancer	3.3e-05	0.000746	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—uterine cancer	3.29e-05	0.000744	CcSEcCtD
Dexamethasone—Vomiting—Dactinomycin—uterine cancer	3.25e-05	0.000735	CcSEcCtD
Dexamethasone—Rash—Dactinomycin—uterine cancer	3.22e-05	0.000729	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—uterine cancer	3.21e-05	0.000727	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—uterine cancer	3.19e-05	0.000722	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—uterine cancer	3.19e-05	0.000721	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—uterine cancer	3.18e-05	0.000721	CcSEcCtD
Dexamethasone—Pain—Etoposide—uterine cancer	3.16e-05	0.000715	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—uterine cancer	3.16e-05	0.000715	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—uterine cancer	3.07e-05	0.000694	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—uterine cancer	3.05e-05	0.00069	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—uterine cancer	3.05e-05	0.000689	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—uterine cancer	3.04e-05	0.000688	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—uterine cancer	3.03e-05	0.000687	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—uterine cancer	3.02e-05	0.000684	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—uterine cancer	2.97e-05	0.000672	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—uterine cancer	2.95e-05	0.000667	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—uterine cancer	2.94e-05	0.000665	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—uterine cancer	2.93e-05	0.000663	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—uterine cancer	2.92e-05	0.000661	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—uterine cancer	2.92e-05	0.000661	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—uterine cancer	2.92e-05	0.000661	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—uterine cancer	2.92e-05	0.00066	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—uterine cancer	2.81e-05	0.000636	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—uterine cancer	2.75e-05	0.000622	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—uterine cancer	2.73e-05	0.000617	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—uterine cancer	2.71e-05	0.000614	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—uterine cancer	2.7e-05	0.000611	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—uterine cancer	2.65e-05	0.0006	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—uterine cancer	2.65e-05	0.000599	CcSEcCtD
Dexamethasone—Pruritus—Etoposide—uterine cancer	2.62e-05	0.000592	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—uterine cancer	2.61e-05	0.00059	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—uterine cancer	2.6e-05	0.000589	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—uterine cancer	2.58e-05	0.000583	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—uterine cancer	2.54e-05	0.000575	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—uterine cancer	2.53e-05	0.000572	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—uterine cancer	2.52e-05	0.000571	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—uterine cancer	2.45e-05	0.000554	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—uterine cancer	2.44e-05	0.000553	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—uterine cancer	2.41e-05	0.000546	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—uterine cancer	2.38e-05	0.00054	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—uterine cancer	2.36e-05	0.000533	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—uterine cancer	2.35e-05	0.000532	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—uterine cancer	2.35e-05	0.000532	CcSEcCtD
Dexamethasone—Rash—Etoposide—uterine cancer	2.33e-05	0.000527	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—uterine cancer	2.33e-05	0.000527	CcSEcCtD
Dexamethasone—Headache—Etoposide—uterine cancer	2.32e-05	0.000524	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—uterine cancer	2.29e-05	0.000518	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—uterine cancer	2.28e-05	0.000516	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—uterine cancer	2.28e-05	0.000515	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—uterine cancer	2.23e-05	0.000505	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—uterine cancer	2.2e-05	0.000498	CcSEcCtD
Dexamethasone—Nausea—Etoposide—uterine cancer	2.2e-05	0.000497	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—uterine cancer	2.19e-05	0.000496	CcSEcCtD
Dexamethasone—ABCB1—lymph node—uterine cancer	2.19e-05	0.000782	CbGeAlD
Dexamethasone—Ill-defined disorder—Doxorubicin—uterine cancer	2.18e-05	0.000493	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—uterine cancer	2.16e-05	0.000489	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—uterine cancer	2.15e-05	0.000487	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—uterine cancer	2.14e-05	0.000483	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—uterine cancer	2.12e-05	0.000479	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—uterine cancer	2.11e-05	0.000478	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—uterine cancer	2.11e-05	0.000477	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—uterine cancer	2.07e-05	0.000469	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—uterine cancer	2.07e-05	0.000469	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—uterine cancer	2.06e-05	0.000467	CcSEcCtD
Dexamethasone—Infection—Epirubicin—uterine cancer	2.06e-05	0.000466	CcSEcCtD
Dexamethasone—Shock—Epirubicin—uterine cancer	2.04e-05	0.000461	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—uterine cancer	2.04e-05	0.000461	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—uterine cancer	2.03e-05	0.00046	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—uterine cancer	2.03e-05	0.000459	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—uterine cancer	2.03e-05	0.000459	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—uterine cancer	2.02e-05	0.000458	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—uterine cancer	2e-05	0.000453	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—uterine cancer	2e-05	0.000453	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—uterine cancer	1.99e-05	0.000451	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—uterine cancer	1.98e-05	0.000447	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—uterine cancer	1.98e-05	0.000447	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—uterine cancer	1.94e-05	0.000438	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—uterine cancer	1.92e-05	0.000434	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—uterine cancer	1.92e-05	0.000434	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—uterine cancer	1.9e-05	0.000431	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.89e-05	0.000427	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—uterine cancer	1.89e-05	0.000427	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—uterine cancer	1.88e-05	0.000426	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—uterine cancer	1.88e-05	0.000425	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—uterine cancer	1.87e-05	0.000424	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—uterine cancer	1.87e-05	0.000423	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—uterine cancer	1.86e-05	0.000421	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—uterine cancer	1.85e-05	0.000419	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—uterine cancer	1.83e-05	0.000414	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—uterine cancer	1.82e-05	0.000413	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—uterine cancer	1.8e-05	0.000408	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—uterine cancer	1.79e-05	0.000405	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—uterine cancer	1.79e-05	0.000405	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—uterine cancer	1.79e-05	0.000404	CcSEcCtD
Dexamethasone—Pain—Epirubicin—uterine cancer	1.77e-05	0.000401	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.75e-05	0.000395	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—uterine cancer	1.73e-05	0.000392	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—uterine cancer	1.72e-05	0.00039	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—uterine cancer	1.71e-05	0.000386	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—uterine cancer	1.69e-05	0.000383	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—uterine cancer	1.69e-05	0.000382	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—uterine cancer	1.67e-05	0.000377	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.66e-05	0.000375	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—uterine cancer	1.65e-05	0.000374	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—uterine cancer	1.65e-05	0.000373	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—uterine cancer	1.64e-05	0.000371	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—uterine cancer	1.64e-05	0.000371	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—uterine cancer	1.64e-05	0.000371	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—uterine cancer	1.58e-05	0.000358	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—uterine cancer	1.57e-05	0.000355	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—uterine cancer	1.52e-05	0.000345	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—uterine cancer	1.52e-05	0.000343	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—uterine cancer	1.52e-05	0.000343	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—uterine cancer	1.49e-05	0.000336	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—uterine cancer	1.47e-05	0.000332	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—uterine cancer	1.42e-05	0.000321	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—uterine cancer	1.38e-05	0.000311	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—uterine cancer	1.37e-05	0.00031	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—uterine cancer	1.36e-05	0.000307	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—uterine cancer	1.32e-05	0.000298	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—uterine cancer	1.31e-05	0.000297	CcSEcCtD
Dexamethasone—Rash—Epirubicin—uterine cancer	1.31e-05	0.000296	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—uterine cancer	1.31e-05	0.000295	CcSEcCtD
Dexamethasone—Headache—Epirubicin—uterine cancer	1.3e-05	0.000294	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—uterine cancer	1.27e-05	0.000287	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—uterine cancer	1.23e-05	0.000279	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—uterine cancer	1.22e-05	0.000276	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—uterine cancer	1.21e-05	0.000274	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—uterine cancer	1.21e-05	0.000273	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—uterine cancer	1.2e-05	0.000272	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—uterine cancer	1.14e-05	0.000258	CcSEcCtD
Dexamethasone—CYP1A1—Metabolism—RRM2—uterine cancer	2.83e-06	7.9e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—VEGFA—uterine cancer	2.83e-06	7.9e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.82e-06	7.87e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CYP19A1—uterine cancer	2.81e-06	7.86e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—STK11—uterine cancer	2.81e-06	7.86e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP11A1—uterine cancer	2.8e-06	7.83e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NRAS—uterine cancer	2.79e-06	7.8e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CYP19A1—uterine cancer	2.79e-06	7.79e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—STK11—uterine cancer	2.79e-06	7.79e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.78e-06	7.76e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—POLD1—uterine cancer	2.77e-06	7.76e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.77e-06	7.73e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—EP300—uterine cancer	2.76e-06	7.71e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKR1C3—uterine cancer	2.75e-06	7.69e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—DCN—uterine cancer	2.74e-06	7.67e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP11A1—uterine cancer	2.74e-06	7.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.74e-06	7.65e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ESR1—uterine cancer	2.73e-06	7.64e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—POLD1—uterine cancer	2.71e-06	7.57e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—MTHFR—uterine cancer	2.67e-06	7.46e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.64e-06	7.39e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.62e-06	7.33e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.6e-06	7.26e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—RRM2—uterine cancer	2.59e-06	7.25e-05	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PIK3CA—uterine cancer	2.59e-06	7.24e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKR1C3—uterine cancer	2.59e-06	7.24e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KRAS—uterine cancer	2.59e-06	7.23e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CYP11A1—uterine cancer	2.59e-06	7.23e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.58e-06	7.23e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CYP19A1—uterine cancer	2.55e-06	7.14e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—STK11—uterine cancer	2.55e-06	7.14e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—POLD1—uterine cancer	2.55e-06	7.14e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKR1C1—uterine cancer	2.53e-06	7.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—POLD1—uterine cancer	2.53e-06	7.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—DCN—uterine cancer	2.52e-06	7.03e-05	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—AKT1—uterine cancer	2.49e-06	6.96e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKR1C3—uterine cancer	2.44e-06	6.83e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—ESR1—uterine cancer	2.43e-06	6.79e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—MTHFR—uterine cancer	2.41e-06	6.74e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.41e-06	6.74e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCL2—uterine cancer	2.41e-06	6.73e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KRAS—uterine cancer	2.4e-06	6.72e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.39e-06	6.67e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PIK3CA—uterine cancer	2.38e-06	6.65e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.37e-06	6.63e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.37e-06	6.62e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.35e-06	6.57e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.33e-06	6.52e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—MTHFR—uterine cancer	2.32e-06	6.49e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—RRM2—uterine cancer	2.31e-06	6.47e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN2B—uterine cancer	2.29e-06	6.41e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—RRM2—uterine cancer	2.26e-06	6.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—DCN—uterine cancer	2.25e-06	6.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.24e-06	6.26e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTEN—uterine cancer	2.21e-06	6.19e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PIK3CA—uterine cancer	2.21e-06	6.17e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—uterine cancer	2.2e-06	6.15e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—DCN—uterine cancer	2.19e-06	6.13e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—STK11—uterine cancer	2.14e-06	5.99e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CYP19A1—uterine cancer	2.14e-06	5.99e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—uterine cancer	2.13e-06	5.97e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—RRM2—uterine cancer	2.13e-06	5.95e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—STAR—uterine cancer	2.13e-06	5.95e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.13e-06	5.95e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.12e-06	5.94e-05	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AKT1—uterine cancer	2.12e-06	5.92e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.12e-06	5.92e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—MTHFR—uterine cancer	2.11e-06	5.9e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—EP300—uterine cancer	2.11e-06	5.9e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—RRM2—uterine cancer	2.11e-06	5.9e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SMAD3—uterine cancer	2.09e-06	5.86e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—MTHFR—uterine cancer	2.09e-06	5.85e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—DCN—uterine cancer	2.07e-06	5.78e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP11A1—uterine cancer	2.06e-06	5.77e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—STK11—uterine cancer	2.06e-06	5.76e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CYP19A1—uterine cancer	2.06e-06	5.76e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—DCN—uterine cancer	2.05e-06	5.73e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.05e-06	5.72e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—uterine cancer	2.04e-06	5.71e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PIK3CA—uterine cancer	2.04e-06	5.7e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTEN—uterine cancer	2.02e-06	5.66e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—STK11—uterine cancer	2.02e-06	5.64e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CYP19A1—uterine cancer	2.02e-06	5.64e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—STK11—uterine cancer	2.01e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.01e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.01e-06	5.63e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ERBB2—uterine cancer	2.01e-06	5.61e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTEN—uterine cancer	2e-06	5.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKR1C3—uterine cancer	2e-06	5.59e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—FGFR2—uterine cancer	2e-06	5.59e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.97e-06	5.5e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKR1C3—uterine cancer	1.95e-06	5.45e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.95e-06	5.44e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—AKT1—uterine cancer	1.94e-06	5.43e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—EP300—uterine cancer	1.93e-06	5.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.93e-06	5.39e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTHFR—uterine cancer	1.92e-06	5.38e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.92e-06	5.36e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—MTHFR—uterine cancer	1.92e-06	5.36e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—EP300—uterine cancer	1.91e-06	5.34e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—STK11—uterine cancer	1.9e-06	5.32e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.9e-06	5.32e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCL8—uterine cancer	1.9e-06	5.32e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CDKN1B—uterine cancer	1.86e-06	5.19e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.84e-06	5.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.82e-06	5.09e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKT1—uterine cancer	1.8e-06	5.04e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.79e-06	4.99e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTEN—uterine cancer	1.78e-06	4.97e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CTNNB1—uterine cancer	1.75e-06	4.91e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—STK11—uterine cancer	1.74e-06	4.88e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.74e-06	4.88e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTEN—uterine cancer	1.71e-06	4.78e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.7e-06	4.76e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—EP300—uterine cancer	1.69e-06	4.74e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—POLD1—uterine cancer	1.67e-06	4.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—uterine cancer	1.67e-06	4.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.64e-06	4.58e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EP300—uterine cancer	1.63e-06	4.56e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MTHFR—uterine cancer	1.61e-06	4.5e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PIK3CA—uterine cancer	1.56e-06	4.37e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.56e-06	4.37e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.56e-06	4.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—STK11—uterine cancer	1.56e-06	4.35e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.56e-06	4.35e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MTHFR—uterine cancer	1.55e-06	4.33e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—VEGFA—uterine cancer	1.54e-06	4.32e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—uterine cancer	1.53e-06	4.27e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—STK11—uterine cancer	1.52e-06	4.25e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP19A1—uterine cancer	1.52e-06	4.25e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MTHFR—uterine cancer	1.52e-06	4.24e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—uterine cancer	1.52e-06	4.24e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTHFR—uterine cancer	1.51e-06	4.23e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—uterine cancer	1.48e-06	4.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.46e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—STK11—uterine cancer	1.43e-06	4e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.43e-06	4e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTHFR—uterine cancer	1.43e-06	4e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PIK3CA—uterine cancer	1.43e-06	3.99e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.42e-06	3.97e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—STK11—uterine cancer	1.42e-06	3.97e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.42e-06	3.97e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—EP300—uterine cancer	1.41e-06	3.96e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PIK3CA—uterine cancer	1.41e-06	3.95e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.39e-06	3.9e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—RRM2—uterine cancer	1.39e-06	3.89e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—DCN—uterine cancer	1.35e-06	3.78e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—uterine cancer	1.34e-06	3.75e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.33e-06	3.73e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—uterine cancer	1.31e-06	3.67e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—uterine cancer	1.31e-06	3.66e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—uterine cancer	1.29e-06	3.61e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—EP300—uterine cancer	1.28e-06	3.58e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—uterine cancer	1.28e-06	3.57e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.27e-06	3.56e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.27e-06	3.55e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.26e-06	3.52e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—uterine cancer	1.25e-06	3.51e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—uterine cancer	1.25e-06	3.51e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—EP300—uterine cancer	1.23e-06	3.44e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—uterine cancer	1.21e-06	3.37e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.2e-06	3.36e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—uterine cancer	1.17e-06	3.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—uterine cancer	1.17e-06	3.27e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—uterine cancer	1.17e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—uterine cancer	1.17e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—uterine cancer	1.16e-06	3.26e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—uterine cancer	1.16e-06	3.25e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.15e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—uterine cancer	1.15e-06	3.23e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—uterine cancer	1.14e-06	3.19e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—EP300—uterine cancer	1.12e-06	3.13e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—uterine cancer	1.12e-06	3.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—EP300—uterine cancer	1.11e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—uterine cancer	1.1e-06	3.07e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—uterine cancer	1.08e-06	3.01e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—uterine cancer	1.07e-06	2.99e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—uterine cancer	1.07e-06	2.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—uterine cancer	1.07e-06	2.98e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.05e-06	2.93e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.03e-06	2.88e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—uterine cancer	1.02e-06	2.86e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EP300—uterine cancer	1.02e-06	2.85e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—EP300—uterine cancer	1.02e-06	2.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—uterine cancer	9.86e-07	2.76e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—uterine cancer	9.54e-07	2.67e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—uterine cancer	9.46e-07	2.64e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.4e-07	2.63e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP19A1—uterine cancer	9.36e-07	2.62e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—STK11—uterine cancer	9.36e-07	2.62e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—uterine cancer	9.11e-07	2.55e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—uterine cancer	8.96e-07	2.51e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—uterine cancer	8.76e-07	2.45e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—uterine cancer	8.61e-07	2.41e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—uterine cancer	8.55e-07	2.39e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—EP300—uterine cancer	8.54e-07	2.39e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—uterine cancer	8.43e-07	2.36e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—uterine cancer	8.42e-07	2.35e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—uterine cancer	8.29e-07	2.32e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—uterine cancer	8.21e-07	2.3e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—uterine cancer	8.21e-07	2.3e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—EP300—uterine cancer	8.21e-07	2.3e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—EP300—uterine cancer	8.04e-07	2.25e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—EP300—uterine cancer	8.03e-07	2.24e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—uterine cancer	7.95e-07	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—uterine cancer	7.73e-07	2.16e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—EP300—uterine cancer	7.58e-07	2.12e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—uterine cancer	7.55e-07	2.11e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—uterine cancer	7.53e-07	2.11e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—uterine cancer	7.44e-07	2.08e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—uterine cancer	7.29e-07	2.04e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—uterine cancer	7.03e-07	1.97e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—uterine cancer	6.98e-07	1.95e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—EP300—uterine cancer	6.95e-07	1.94e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—uterine cancer	6.77e-07	1.89e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—uterine cancer	6.71e-07	1.88e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—uterine cancer	6.51e-07	1.82e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—uterine cancer	6.35e-07	1.78e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—uterine cancer	6.32e-07	1.77e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—EP300—uterine cancer	6.21e-07	1.74e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—uterine cancer	6.17e-07	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—uterine cancer	6.15e-07	1.72e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—uterine cancer	6.07e-07	1.7e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—EP300—uterine cancer	6.06e-07	1.69e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—uterine cancer	5.98e-07	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—uterine cancer	5.95e-07	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—uterine cancer	5.94e-07	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—uterine cancer	5.93e-07	1.66e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—EP300—uterine cancer	5.71e-07	1.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—EP300—uterine cancer	5.66e-07	1.58e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—uterine cancer	5.61e-07	1.57e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—uterine cancer	5.16e-07	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—uterine cancer	5.14e-07	1.44e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—uterine cancer	4.96e-07	1.39e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—uterine cancer	4.86e-07	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—uterine cancer	4.85e-07	1.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.59e-07	1.28e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—uterine cancer	4.58e-07	1.28e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—uterine cancer	4.48e-07	1.25e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.22e-07	1.18e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—uterine cancer	4.2e-07	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.19e-07	1.17e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—uterine cancer	3.91e-07	1.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—uterine cancer	3.75e-07	1.05e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—EP300—uterine cancer	3.73e-07	1.04e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—uterine cancer	3.66e-07	1.02e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—uterine cancer	3.45e-07	9.64e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—uterine cancer	3.42e-07	9.56e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.76e-07	7.72e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—uterine cancer	2.26e-07	6.31e-06	CbGpPWpGaD
